ACADIA Pharmaceuticals Inc.
ACAD · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $71,779 | $26,666 | $18,987 | $143,742 |
| Dep. & Amort. | $2,950 | -$1,159 | $2,951 | $5,214 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $13,180 | $14,340 | $11,380 | $10,450 |
| Change in WC | -$12,519 | $21,551 | -$10,879 | $30,307 |
| Other Non-Cash | -$1,102 | $2,558 | -$2,116 | -$149,332 |
| Operating Cash Flow | $74,288 | $63,956 | $20,323 | $40,381 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$388 | $98,541 | -$98,838 | -$453 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$204,553 | -$174,387 | -$156,011 | -$135,762 |
| Inv. Sales/Matur. | $125,589 | $131,390 | $130,800 | $111,850 |
| Other Inv. Act. | $0 | -$98,838 | $0 | $146,515 |
| Investing Cash Flow | -$79,352 | -$43,294 | -$124,049 | $122,150 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $9,423 | $15,956 | $1,838 | $1,969 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $9,423 | $15,956 | $1,838 | $1,969 |
| Forex Effect | $0 | $24 | -$5 | -$60 |
| Net Chg. in Cash | $4,359 | $36,642 | -$101,893 | $164,440 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $263,108 | $226,466 | $328,359 | $163,919 |
| End Cash | $267,467 | $263,108 | $226,466 | $328,359 |
| Free Cash Flow | $73,900 | $162,497 | -$78,515 | $39,928 |